I think this “delay” is due to the factor that this DMT (like Alemtuzumab) is a non continuous drug, ie, pwMS stay for long periods without any medication, apart from monthly blood and urine control. These drugs are now in the market with prices much higherthan the “off label” that preceded (leukaemia drugs). FARMACEUTICAL LOBBY
Ok, but only clinical trials, no new drug was developed !
Many “clinical trials” were made by doctors/investigatores using the “off label drugs” in real pwMS.
Ok, but only clinical trials, no new drug was developed !
Many “clinical trials” were made by doctors/investigators using the “off label drugs” in real MSérs
I think this “delay” is due to the factor that this DMT (like Alemtuzumab) is a non continuous drug, ie, pwMS stay for long periods without any medication, apart from monthly blood and urine control. These drugs are now in the market with prices much higherthan the “off label” that preceded (leukaemia drugs). FARMACEUTICAL LOBBY
Yes but meanwhile hundreds of million € were spent in clinical trials to prove the efficacy of these “old” drugs in MS… and they could have failed.
Ok, but only clinical trials, no new drug was developed !
Many “clinical trials” were made by doctors/investigatores using the “off label drugs” in real pwMS.
Innovation takes time and costs..and without approval of the regulators things go no where.
Ok, but only clinical trials, no new drug was developed !
Many “clinical trials” were made by doctors/investigators using the “off label drugs” in real MSérs